Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20513 |
IDO1-IN-1
IDO1 inhibitor 1,2 HzBTZ,2-肼基苯并噻唑,IDO1IN1,2-HzBTZ,IDO1-inhibitor-1 |
IDO | Metabolism |
IDO1-IN-1 (2 HzBTZ) 是一种吲哚胺 2,3-双加氧酶 1 (IDO1) 抑制剂。 | |||
T11901 |
IDO1-IN-5
|
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-5 是可透过血脑屏障的、选择性的IDO1抑制剂,能够与缺乏血红素的 apo-IDO1 结合,但无法与成熟血红素的 IDO1 结合。 | |||
T39839 |
IDO1-IN-11
IDO1-IN-11 |
||
IDO1-IN-11 is an IDO1 inhibitor with an IC 50 value of 0.6 nM. | |||
T39888 |
IDO1-IN-7
IDO1-IN-7 |
||
IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research. | |||
T39946 |
IDO1-IN-12
IDO1-IN-12 |
||
IDO1-IN-12 is a potent and orally available IDO1 inhibitor. | |||
T11624 | IDO1-IN-2 | IDO | Metabolism |
IDO1-IN-2 is a potent and selective IDO1 inhibitor with IC50s of 81 nM, 59 nM (mouse), and 28 nM (rat), respectively. It has anti-cancer activity. | |||
T12668 |
(Rac)-IDO1-IN-5
|
Others | Others |
(Rac)-IDO1-IN-5 is a racemate of IDO1-IN-5, a potent, selective, and brain-penetrating inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity. It specifically binds to apo-IDO1, which lacks heme, instead of mature heme-bound IDO1. | |||
T12801 |
(S)-IDO1-IN-5
|
Others | Others |
(S)-IDO1-IN-5 is an active S-isomer of IDO1-IN-5. (S)-IDO1-IN-5 binds to IDOL(IC50 value less than 1.5 µΜ). | |||
T61385 |
IDO1/TDO-IN-1
|
||
IDO1/TDO-IN-1 (30) is a highly effective inhibitor that targets both IDO1 and TDO enzymes with uncompetitive (Ki = 0.23 μM) and competitive (Ki = 0.73 μM) mechanisms, respectively. This compound, IDO1/TDO-IN-1 (30), exhibits a significant capacity to induce cell apoptosis via the potential mitochondria-mediated Bcl-2/Bax pathway [1]. | |||
T63222 | IDO1/2-IN-1 | ||
IDO1/2-IN-1 是一个有效的、口服具有活力的 IDO1/IDO2 双重抑制剂,对 IDO1 和 IDO2 的IC50分别为 28 nM 和 144 nM,表现出抗肿瘤作用。 | |||
T63651 | IDO1/2-IN-1 hydrochloride | ||
IDO1/2-IN-1 hydrochloride 是一个有效的 IDO1 (IC50: 28 nM) 和 IDO2 (IC50: 144 nM) 双重抑制剂,口服具有活力。IDO1/2-IN-1 hydrochloride 表现出抗肿瘤作用。 | |||
T11616 |
IDO-IN-13
GS-4361 |
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO-IN-13 (GS-4361) 是 indoleamine 2,3-dioxygenase 1 抑制剂,EC50=17 nM。 | |||
T61789 | IDO1-IN-14 | ||
IDO1-IN-14 (compound 4a) is a highly effective inhibitor of the IDO1 enzyme, exhibiting an IC50 value of 396.9 nM. Additionally, IDO1-IN-14 demonstrates excellent suppression of cellular IDO1 activity, as observed in HeLa cells with an EC50 value of 3393 nM [1]. | |||
T63780 |
IDO1-IN-16
|
||
IDO1-IN-16 (I-1) 是一种 IDO1 抑制剂,能够靶向holo-IDO1 (IC50: 127 nM)。 | |||
T60499 |
IDO1/TDO-IN-2
|
||
IDO1/TDO-IN-2 (Compound 1) 是有效的IDO1/TDO 双重抑制剂,IC50s 分别为 0.1 和 0.07 μM,具有癌症研究的潜力。 | |||
T61140 |
IDO1/TDO-IN-3
|
||
IDO1/TDO-IN-3 is a powerful inhibitor targeting IDO1 and TDO enzymes. It displays noteworthy effectiveness against IDO1 (IC50: 0.005 μM) and TDO (IC50: 0.004 μM). Additionally, IDO1/TDO-IN-3 demonstrates considerable in vivo anti-tumor properties while exhibiting no apparent toxicity [1]. | |||
T82082 | IDO1-IN-23 | Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-23(化合物41)是一种有效的人类IDO1抑制剂,具备13 μM的IC50值。 | |||
T60318 | IDO1/TDO-IN-4 | ||
IDO1/TDO-IN-4 显示出对 IDO1 (IC50 = 3.53 μM) 和 TDO (IC50 = 1.15 μM) 的有效抑制作用,并且具有可接受的安全性和药代动力学特性。IDO1/TDO-IN-4 可与 IDO1 形成氢键,与 TDO 产生 π-π 堆积相互作用。 IDO1/TDO-IN-4 可用于抑郁症以及炎症引起的抑郁症的研究。 | |||
T78687 | IDO1-IN-21 | Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-21(化合物10m)为IDO1抑制剂,其IC50值为0.64 μM。该化合物在小鼠体内可有效抑制肿瘤生长。 | |||
T78795 |
IDO1/TDO-IN-6
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1/TDO-IN-6(compound 11)为IDO1/TDO双重抑制剂,其IC50值分别为2.25 μM和2.89 μM。在抑制IDO1和TDO方面,其Ki值分别为1.9 μM和3.1 μM。IDO1/TDO-IN-6适用于癌症与免疫学领域的研究。 | |||
T73111 | IDO1-IN-17 | ||
IDO1-IN-17 (I-4) 是IDO1的抑制剂,其在 hela 细胞中的IC50值为 0.44 μM。 | |||
T37329 |
PROTAC IDO1 Degrader-1
PROTAC IDO1 Degrader-1 |
||
PROTAC IDO1 Degrader-1 is the first potent IDO1 (indoleamine 2,3-dioxygenase 1) degrader that hijacks IDO1 to CRBN E3 ligase to introduce IDO1 into UPS and eventually achieve ubiquitination and degradation (DC50=2.84 μM). PROTAC IDO1 Degrader-1 moderately improves the tumor-killing activity of H ER2 CAR-T cells[1]. PROTAC IDO1 Degrader-1 (compound 2c) (10 μM; 24 hours) notably decreases IDO1 level induced by IFN-γ[1].PROTAC IDO1 Degrader-1 and IFN-γ (5 ng/mL) are incubated with HeLa cells for 24... | |||
T78235 |
4-Phenyl-1H-1,2,3-triazole
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
4-Phenyl-1H-1,2,3-triazole,一种IDO1抑制剂(IC50:60 μM),可应用于癌症研究。 | |||
T78975 |
IDO1-IN-22
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-22(Compound 3)是一种效能显著的IDO1抑制剂,具备低纳摩尔级生化活性(hIDO1 IC50:67.4 nM)以及显著的细胞内抑制效果(HeLa细胞中hIDO1 IC50:17.6 nM)。在小鼠LLC异种移植模型中表现出卓越的抗肿瘤效果,并表现出有利的药代动力学(PK)特性。 | |||
T73512 | ZC0109 | ||
ZC0109 是 IDO1和硫氧还蛋白还原酶 1 (TrxR1) 的双抑制剂,IC50分别为 50 nM 和 3.0 μM。ZC0109 诱导活性氧 (ROS) 积累,使细胞周期阻滞于 G1/S 期,导致癌细胞凋亡 (apoptosis)。 | |||
T60618 |
ZC0101
|
||
ZC0101 是一种有效的、具有口服活性的 IDO1和 TrxR 双重抑制剂,IC50值分别为 0.084 μM 和 7.98 μM。ZC0101 可诱导癌细胞的凋亡和活性氧的积累。 | |||
T36645 |
CAY10763
CAY10763 |
||
CAY10763 is a dual inhibitor of indolamine 2,3-dioxygenase 1 (IDO1; IC50= 46 nM) and STAT3 activation.1It binds to STAT3 (Kd= 530 nM) and selectively reduces the levels of STAT3 phosphorylated at the tyrosine in position 705 (STAT3Y705) over phosphorylated STAT3S727, STAT1, and STAT5 in SKOV3 cells when used at a concentration of 500 nM. It also inhibits STAT3 nuclear translocation in SKOV3 cells. CAY10763 is cytotoxic to HCT116, SKOV3, A549, and HepG2 cancer cells (IC50s = 37, 28, 33, and 12 nM... |